Wordlesstech2023-09-13T10:26:13+03:00

Approval for Alzheimer’s Drug

Jun 10, 2021|

The U.S. Food and Drug Administration approved Aduhelm (aducanumab) for the treatment of Alzheimer’s, a debilitating disease affecting 6.2 million Americans.